Lilly's Free Compound Screening Will Draw Many Takers [View article]
Access Pharmaceuticals, a biotech company with many oncology products in pipeline, put out a press release today regarding the launch of their FDA approved drug MuGard in 4 of 27 markets in Europe. Check it out
Skystar on the NASDAQ with Big EPS and Low Float [View article]
Great article! On another note, Access Pharmaceuticals put out a press release today regarding their global launch of their FDA approved product MuGard in 4 of 27 countries in Europe. A stock to check out for sure.
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch [View article]
Access Pharmaceuticals released a press release today regarding the global launch of their FDA approved MuGard in 4 of the 27 countries they are marketing to in Europe. What about Access's possibilities?
Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS [View article]
What about Access Pharmaceuticals? They just announced the release of their drug MuGard in 4 of the 27 European countries they plan on launching in. Any thoughts?
Sort by:
Latest | Highest ratedLilly's Free Compound Screening Will Draw Many Takers [View article]
Skystar on the NASDAQ with Big EPS and Low Float [View article]
Luminex: Expect Strong Growth in 2009 [View article]
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch [View article]
Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS [View article]